FOI release

HSCNI notifications re prescription only medicines

Some or all of the information requested may not have been provided because we determined that the request was vexatious.

Case reference FOI2026/00318

Received 23 March 2026

Published 6 May 2026

Request

Were HSCNI notified that prescription only medicines were being supplied to their harm reduction contracts from unlicensed premises? Please restrict your search to emails sent from members of the following teams only: • The Criminal Enforcement team within MHRA's Compliance unit • The Good Distribution Practice team within MHRA's Compliance unit Please include emails sent to any @hscni.net domain including but not limited to @southerntrust.hscni.net and @setrust.hscni.net, covering the period 1 July 2025 to 31 December 2025. If the cost limit is still exceeded following this narrowing, please contact me before refusing and advise what further narrowing would bring the request within scope.

Response

See attached

Documents

• FOI2026_00216 (redacted).pdf (1.3 MB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.